Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Whey protein drink can control erratic glucose levels associated with type 2 diabetes

Blood sugar surges - after-meal glucose "spikes" - can be life threatening for the 29 million Americans with diabetes. Diabetic blood sugar spikes have been linked to cardiovascular disease, cancer, Alzheimer's disease, kidney failure, and retinal damage.

5 Aug 2014

$5.8 million grant for coalition project to help reduce strokes and heart attacks in San Diego County

Approximately 84 million people in the United States suffer from some form of cardiovascular disease, and about 720,000 Americans have a heart attack every year, which works out to one every 44 seconds.

5 Aug 2014

Frontiers launches Frontiers in Cardiovascular Medicine journal

Swiss open-access publisher Frontiers, part of the Nature Publishing Group family, is pleased to announce the launch of Frontiers in Cardiovascular Medicine, a new open-access medical journal.

5 Aug 2014

Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

The herpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, according to a Kaiser Permanente study published today in the journal Clinical Infectious Diseases.

5 Aug 2014

ACA provides opportunities to increase availability of CR programs in workplace

Through financial incentives and an emphasis on proven health outcomes, the Affordable Care Act (ACA) provides opportunities to increase the availability of cardiac rehabilitation (CR) programs—including offering CR as part of worksite health programs (WHPs), according to an article in the August Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

4 Aug 2014

Salt poses cardiovascular risk in diabetic patients

A diet high in salt increases the risk of cardiovascular disease in patients with Type 2 diabetes, show data from the Japan Diabetes Complications Study.

1 Aug 2014

New joint ESC/ESA Guidelines on non-cardiac surgery

The publication of the new joint ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management introduces a number of recommendations in the field. Among other topics, the Guidelines include updated information on the use of clinical indices and biomarkers in risk assessment, and the use of novel anticoagulants, statins, aspirin and beta-blockers in risk mitigation.

1 Aug 2014

Tree nuts have positive impact on glycemic control in diabetes and on metabolic syndrome criteria

Two new meta-analyses involving tree nuts (almonds, Brazil nuts, cashews, hazelnuts, macadamias, pecans, pine nuts, pistachios and walnuts) were recently published in the online publications, British Medical Journal Open (BMJ Open) and PLOS ONE.

1 Aug 2014

New smartphone app to improve quality of life for older adults

A team of researchers from the Universitat Politècnica de Catalunya · BarcelonaTech (UPC) and the Universitat Autònoma de Barcelona (UAB) is creating a smartphone app that will help older adults to understand their state of health and develop healthier habits.

31 Jul 2014

Researchers to develop global database on situation and evolution of Chagas disease

The Centre for Development Cooperation (CCD) and several research groups of the Universitat Politècnica de Catalunya (UPC) are working together with the World Health Organization (WHO) to develop a global database on the situation and evolution of Chagas disease.

31 Jul 2014

EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

Takeda Pharmaceuticals International GmbH today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued positive opinions for updates to the Summary of Product Characteristics (SmPC) for Vipidia (alogliptin) and the fixed-dose combination (FDC) therapies Vipdomet (alogliptin and metformin) and Incresync (alogliptin and pioglitazone).

30 Jul 2014

CardioNova initiates Phase 1b clinical trial with AtheroNova's AHRO-001

AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001.

30 Jul 2014

Running for just 10 minutes a day can reduce risk of death

Need an incentive to lace up your shoes and go for a run? A new Iowa State University study, published in the Journal of the American College of Cardiology, found running for just five or 10 minutes a day can significantly reduce your risk of death from cardiovascular disease.

30 Jul 2014

Researchers examine impact of extreme temperatures on number of deaths

When temperatures are extremely high or low, there is a significant increase in the number of deaths caused by heart failure or stroke.

29 Jul 2014

Study suggests healthy diet, sleep and exercise can mitigate negative impacts of stress

A new study from UC San Francisco is the first to show that while the impact of life's stressors accumulate overtime and accelerate cellular aging, these negative effects may be reduced by maintaining a healthy diet, exercising and sleeping well.

29 Jul 2014

Cardioxyl reports positive results from CXL-1427 Phase I trial for treatment of ADHF

Cardioxyl Pharmaceuticals, Inc. announced today the positive results of a clinical trial demonstrating that CXL-1427, a novel potential treatment for acute decompensated heart failure (ADHF), was well tolerated in healthy volunteers.

28 Jul 2014

Researchers examine effects of bacteria in fighting against obesity

A probiotic that prevents obesity could be on the horizon. Bacteria that produce a therapeutic compound in the gut inhibit weight gain, insulin resistance and other adverse effects of a high-fat diet in mice, Vanderbilt University investigators have discovered.

26 Jul 2014

Cardiovascular Research Foundation to co-sponsor 2014 VEINS conference

VEINS is an established Venous Endovascular Interventional Strategies group comprised of experts in the field whose primary aim is to provide a "How To" meeting for cardiologists and other healthcare providers who are interested in advancing their knowledge and skills in venous interventions and whose ultimate goal is developing their own comprehensive venous interventional program.

25 Jul 2014

Researchers recommend low carbohydrate diet for Type 1 and Type 2 diabetes

A new study involving researchers from the University of Alabama at Birmingham and other institutions says patients with Type 1 and Type 2 diabetes should eat a diet low in carbohydrates.

25 Jul 2014

Researchers receive inaugural funding from AHA to prevent heart disease and stroke

Researchers and clinicians at UT Southwestern Medical Center are among a small, select group at U.S. universities to receive inaugural funding from the American Heart Association (AHA) for work that takes aim at heart disease and stroke.

24 Jul 2014

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Whey protein drink can control erratic glucose levels associated with type 2 diabetes

$5.8 million grant for coalition project to help reduce strokes and heart attacks in San Diego County

Frontiers launches Frontiers in Cardiovascular Medicine journal

Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

ACA provides opportunities to increase availability of CR programs in workplace

Salt poses cardiovascular risk in diabetic patients

New joint ESC/ESA Guidelines on non-cardiac surgery

Tree nuts have positive impact on glycemic control in diabetes and on metabolic syndrome criteria

New smartphone app to improve quality of life for older adults

Researchers to develop global database on situation and evolution of Chagas disease

EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

CardioNova initiates Phase 1b clinical trial with AtheroNova's AHRO-001

Running for just 10 minutes a day can reduce risk of death

Researchers examine impact of extreme temperatures on number of deaths

Study suggests healthy diet, sleep and exercise can mitigate negative impacts of stress

Cardioxyl reports positive results from CXL-1427 Phase I trial for treatment of ADHF

Researchers examine effects of bacteria in fighting against obesity

Cardiovascular Research Foundation to co-sponsor 2014 VEINS conference

Researchers recommend low carbohydrate diet for Type 1 and Type 2 diabetes

Researchers receive inaugural funding from AHA to prevent heart disease and stroke

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in